iSelect Fund Management, LLC is a venture capital firm founded in 2014 and based in St. Louis, Missouri. The firm specializes in early-stage investments, focusing on series seed, A, and B rounds, and targets various sectors, including agriculture, healthcare, resource efficiency, education services, B2B software, and energy. In agriculture, iSelect emphasizes plant sciences, seed genetics, and sustainability, while in healthcare, it prioritizes immunotherapy and personalized medicine. The firm primarily invests in companies based in the United States, particularly in the Midwest and South, and also considers opportunities in India. iSelect seeks to make meaningful investments that address significant global challenges, such as healthcare costs and food security, with a minimum investment threshold of $0.05 million and a preference for a holding period of five to seven years or longer.
BioLumic is a New Zealand-based company that specializes in innovative lighting solutions for horticultural producers, utilizing smart light array technology. Founded in 2012, BioLumic focuses on enhancing the quality and growth of transplant crop seedlings, as well as improving the growth and quality of indoor leafy vegetables and salad herbs. The company employs a photogenics platform that uses light signals to activate plant growth and unlock the genetic potential of various crops, including soybean, cannabis, and other vegetables and fruits. BioLumic's systems leverage ultraviolet radiation to regulate plant responses, resulting in increased crop yields, improved vigor, enhanced disease and pest resistance, and better crop composition, all without the need for chemicals or amendments.
Edacious
Seed Round in 2025
Edacious is a Public Benefit Corporation that focuses on developing a food verification system based on radical transparency. This innovative platform aims to foster a nourishing and sustainable agri-food system by prioritizing the verification of food quality. Edacious serves the packaged goods, retail, and supply chain industries, providing businesses with technology that enhances product integrity while benefiting the environment. Through its commitment to transparency, Edacious seeks to improve the overall outcomes of the agri-food sector.
One.bio
Series A in 2024
One.bio is a biotechnology spinout from UC Davis that specializes in developing naturally-derived oligosaccharides for applications in food, agriculture, and biopharmaceuticals. Utilizing proprietary technology, the company creates innovative ingredients aimed at modulating the microbiome and enhancing immune function. This focus allows One.bio to provide clients with access to novel prebiotics and therapies that support both human and animal health. By unlocking the benefits of nutrition, One.bio aims to contribute to improved longevity and overall well-being.
Holobiome
Seed Round in 2024
Holobiome is a biotechnology company based in Cambridge, Massachusetts, focused on developing microbiome-based therapeutics for treating diseases of the enteric and central nervous systems. Established in 2015, the company aims to address mental health issues such as depression and anxiety by leveraging the gut-brain axis through next-generation probiotics. By mapping and manipulating the human gut microbiome, Holobiome provides healthcare providers with innovative interventions that enhance patient recovery and improve metabolic and immune responses, all while minimizing pain and suffering associated with these conditions.
Triplebar
Venture Round in 2023
Triplebar is a biotechnology company focused on advancing sustainability through innovative research and synthetic biology. It operates a platform that harnesses the principles of evolution to facilitate the discovery of solutions for various challenges in food supply production, processing, and packaging. Utilizing its Hyper-Throughput™ Screening system, the company enables users to test millions of potential solutions efficiently, significantly accelerating the research and development process. By leveraging biotechnology, Triplebar aims to empower researchers and industries to identify and implement complex solutions that enhance sustainability in various sectors.
PreventScripts
Venture Round in 2023
PreventScripts develops a prevention management platform aimed at assisting primary care providers in managing at-risk populations to prevent chronic diseases. The platform offers a comprehensive personal health improvement tool for prediabetic and prehypertensive patients, utilizing connected health device data and gamified behavior tracking. This user-friendly software features a color-coded tracker that helps patients identify daily behavior changes conducive to healthier habits. By promoting the philosophy of "A little better every day," PreventScripts encourages small, incremental changes to achieve broader health goals. The company collaborates with healthcare providers to implement reimbursable clinical preventive services, making proven behavior change practices accessible and actionable. Additionally, both Android and enterprise population health dashboards are currently in development to enhance the platform's capabilities.
Mend
Series A in 2023
MEND is a life sciences company dedicated to advancing health and recovery through targeted clinical nutrition and medical food interventions. The company focuses on researching and developing products that enhance patient outcomes in various contexts, including injury recovery, surgical recovery, aging, and physical performance. MEND's solutions have been widely adopted by hospitals, health systems, and professional sports teams across major leagues, as well as by the elite forces of the US Military. Through its commitment to ongoing research and development, MEND aims to empower caregivers and improve health outcomes for individuals facing diverse health challenges.
Flywheel.io
Series D in 2023
Flywheel is a data management and analysis platform built specifically for scientists and the researcher's workflow. They empower research momentum by focusing on data and medical image capture, content management, scientific computation, and collaboration. With reproducible research in mind, they combine open-source methods from top universities, a modern web user interface, and an extensible compute engine based on containerization technology. The result is a software platform to accelerate discovery and help researchers do science, not IT. Flywheel accelerates new scientific discoveries in life-science, biotech, and academic imaging research through cloud-scale collaboration. As a result, imaging researchers are able to avoid innovation bottlenecks, and accelerate discovery by doing more science, and less IT.
Pluton Biosciences
Series A in 2023
Pluton Biosciences is a bioscience research company that specializes in the testing and discovery of microbes for the development of various products, primarily focusing on biopesticides and pharmaceuticals. Utilizing an innovative platform, the company mines and clones microbes to generate a range of beneficial products aimed at enhancing biopesticides, crop protection, human health, and bioremediation. By harnessing the potential of bacteria, fungi, and viruses, Pluton Biosciences enables medical researchers and agricultural professionals to explore sustainable and all-natural solutions for various applications, contributing to advancements in both environmental and health-related sectors.
Harpe Bio
Convertible Note in 2023
Harpe Bioherbicide Solutions is a Raleigh-based company that provides sustainable weed-management solutions for organic and industrial agriculture. Harpe Bio's technologies deliver natural crop protection by utilizing a variety of plant extracts. The plant extracts serve as a platform that may be tailored to various weed management circumstances. Harpe's herbicide platform can be used alone or in conjunction with any currently marketed herbicide. Harpe's new modes and areas of action will improve synthetic herbicide efficacy, including the reduction of resistant weed populations.
Mercy BioAnalytics
Series A in 2023
Mercy BioAnalytics is a biotechnology company based in Natick, Massachusetts, founded in 2018 by Paul Blavin and Joseph Sedlak. The company focuses on improving cancer outcomes through early detection by utilizing a novel liquid biopsy assay platform. This platform analyzes tumor-derived extracellular vesicles (EVs), which are abundant in blood and provide critical information about their parent cells. By leveraging these EVs, Mercy BioAnalytics aims to enable the detection of various types of cancer at its earliest stages, ultimately striving to enhance patient outcomes and save lives.
Growers Edge
Series B in 2023
Growers Edge is a company focused on enhancing farmer profitability through innovative, data-driven financial technology solutions tailored for the agricultural sector. Based in Johnston, Iowa, the company utilizes data science and advanced algorithms to create warranty-backed crop management plans. These offerings enable agricultural retailers and lenders to provide embedded financial products and tools, including white-labeled lending platforms and land valuation resources. By addressing financial gaps and transforming the sale of agricultural inputs and services, Growers Edge empowers farmers to adopt new technologies that enhance their income and overall profitability. The company is led by experienced professionals in crop management and is supported by prominent investors in the agtech industry.
EarthOptics
Series B in 2023
EarthOptics is a company focused on sustainable agricultural management through the development of a global soil cloud platform. Utilizing advanced sensors and machine learning, EarthOptics creates highly accurate soil maps by analyzing far fewer soil samples. The platform provides detailed insights into various soil attributes, including compaction, fertility, and carbon levels. This technology empowers farmers, ranchers, and land managers to make informed decisions that enhance profitability and sustainability in soil management. Additionally, EarthOptics offers near-real-time actionable data that aids in monitoring soil health, benefiting both agricultural practices and carbon credit verification efforts.
AgriWebb
Series B in 2022
AgriWebb is a software company specializing in the livestock production sector, offering a cloud-based farm management platform that facilitates real-time data collection and analysis. The platform enables farmers to track livestock actions, manage paddock treatments, and record crop information, all while maintaining transparency and efficiency. AgriWebb's tools support farmers in making informed decisions by providing essential insights into their operations, whether online or offline. Founded by a team with five generations of livestock production experience, AgriWebb aims to revolutionize the industry through data-driven practices, enhancing management efficiency and fostering better integration across supply chains.
Pattern Ag
Series B in 2022
Pattern Ag specializes in soil microbiome analysis, offering farmers insights to optimize their agricultural inputs. The company's precision agriculture platform utilizes high-resolution mapping of soil DNA to provide actionable intelligence tailored to the specific pest and disease challenges faced by corn and soybean farmers. By delivering recommendations on crop protection, seed selection, and fertility needs, Pattern Ag helps farmers make informed decisions about what to purchase and when to apply these solutions. This focus on data-driven insights not only aims to enhance crop yields but also to improve overall farm productivity and sustainability.
Vestaron
Series C in 2022
Vestaron Corporation specializes in the development, manufacture, and sale of peptide-based biologic crop protection products. Founded in 2005 and headquartered in Durham, North Carolina, with a research and development center in Kalamazoo, Michigan, Vestaron offers a range of bioinsecticides including Spear-T, Spear-Lep, and Leprotec, which target various pests in vegetables, fruits, and field crops. The company aims to enhance crop safety, efficacy, and sustainability by providing biopesticides that address resistance issues while ensuring safety for workers and the environment. Vestaron has received notable accolades for its innovative solutions, including the Bernard Blum Award and the Green Chemistry Challenge Award, recognizing its commitment to environmental stewardship and effective crop protection.
Bond Pet Foods
Venture Round in 2022
Bond Pet Foods is a Boulder, Colorado-based company that specializes in creating sustainable pet food products using biotechnology. Founded in 2015, the company develops meat proteins derived from animal cells without the need for animal slaughter, and utilizes fermentation processes similar to those found in craft brewing. The proteins are cultivated in fermentation tanks and are supplemented with a nutrient-rich broth containing vitamins, sugars, and minerals, ensuring they meet the nutritional needs of companion animals. By offering all-natural and animal-free alternatives, Bond Pet Foods aims to provide environmentally friendly options for pet owners while supplying its innovative ingredients to pet food manufacturers for incorporation into their recipes and product lines.
Vestaron
Series C in 2022
Vestaron Corporation specializes in the development, manufacture, and sale of peptide-based biologic crop protection products. Founded in 2005 and headquartered in Durham, North Carolina, with a research and development center in Kalamazoo, Michigan, Vestaron offers a range of bioinsecticides including Spear-T, Spear-Lep, and Leprotec, which target various pests in vegetables, fruits, and field crops. The company aims to enhance crop safety, efficacy, and sustainability by providing biopesticides that address resistance issues while ensuring safety for workers and the environment. Vestaron has received notable accolades for its innovative solutions, including the Bernard Blum Award and the Green Chemistry Challenge Award, recognizing its commitment to environmental stewardship and effective crop protection.
Brightseed
Series B in 2022
Brightseed, Inc. is a biotechnology company based in San Francisco, California, that specializes in the discovery of bioactive compounds in plants to enhance human health. Utilizing its advanced Forager platform, which employs artificial intelligence and machine learning algorithms, Brightseed accelerates the identification and validation of clinically beneficial molecules. This innovative approach enables the company to uncover connections between natural compounds and health outcomes, revealing the potential of bioactives that have previously remained uncharted. By integrating these discoveries back into the food supply chain, Brightseed collaborates with various companies across the consumer health continuum to develop science-backed health solutions aimed at managing chronic diseases and improving overall quality of life. Founded in 2017, Brightseed is committed to exploring the untapped resources of the plant kingdom to address pressing health challenges.
One.bio
Series A in 2022
One.bio is a biotechnology spinout from UC Davis that specializes in developing naturally-derived oligosaccharides for applications in food, agriculture, and biopharmaceuticals. Utilizing proprietary technology, the company creates innovative ingredients aimed at modulating the microbiome and enhancing immune function. This focus allows One.bio to provide clients with access to novel prebiotics and therapies that support both human and animal health. By unlocking the benefits of nutrition, One.bio aims to contribute to improved longevity and overall well-being.
Immunophotonics
Series B in 2022
ImmunoPhotonics, Inc. is a biotechnology company focused on developing innovative immunotherapy treatments for cancer, specifically targeting metastatic solid tumors. Founded in 2008 and located in Columbia, Missouri, the company has created a proprietary drug product designed to function as a minimally invasive therapeutic cancer vaccine. This product is administered through intratumoral injection following tumor ablation, leveraging tumor-associated neoantigens to stimulate a systemic anti-tumor immune response. By transforming the process of tumor ablation into a therapeutic approach, ImmunoPhotonics aims to enhance treatment options for patients with late-stage metastatic cancers. The company has also established a strategic partnership with Veterinary Cancer Therapeutics, LLC to further its mission in cancer treatment.
Molecular Assemblies
Series B in 2022
Molecular Assemblies, Inc. is a San Diego-based company specializing in enzymatic DNA synthesis technology, which facilitates the development of DNA-based products across various industries. Founded in 2013, the company focuses on creating long, high-quality, sequence-specific DNA in a reliable, affordable, and sustainable manner, inspired by natural processes. Its technology has applications in industrial synthetic biology, personalized therapeutics, precision diagnostics, information storage, nanotechnology, and DNA electronics. The firm boasts a skilled executive and scientific team, supported by a robust intellectual property portfolio. Molecular Assemblies has garnered investments from a range of venture capital sources, indicating strong interest in its innovative approach to DNA synthesis.
Harpe Bio
Series A in 2022
Harpe Bioherbicide Solutions is a Raleigh-based company that provides sustainable weed-management solutions for organic and industrial agriculture. Harpe Bio's technologies deliver natural crop protection by utilizing a variety of plant extracts. The plant extracts serve as a platform that may be tailored to various weed management circumstances. Harpe's herbicide platform can be used alone or in conjunction with any currently marketed herbicide. Harpe's new modes and areas of action will improve synthetic herbicide efficacy, including the reduction of resistant weed populations.
Kula Bio
Series A in 2022
Kula Bio, Inc. is focused on developing innovative biological solutions for modern agriculture. Founded in 2018 and based in Somerville, Massachusetts, the company specializes in the production of organic biofertilizers using nitrogen-fixing microbes charged with renewable energy. By enhancing natural microbial processes, Kula Bio aims to create affordable and sustainable fertilization methods that enable farmers to increase their yields while promoting environmental stewardship. The company's approach seeks to disrupt traditional synthetic fertilizers, bridging the gap between effective agricultural practices and the responsible management of natural resources.
Cyrus Biotechnology
Series B in 2021
Cyrus Biotechnology, Inc. is a Seattle-based company that specializes in developing advanced software for protein structure prediction and design. Founded in 2014, it offers several key products, including Rosetta, a tool designed to create biologically active proteins for various medical applications such as treating brain cancer and addressing Celiac Disease. The company also provides Cyrus Bench, an enterprise version of Rosetta that includes a comprehensive suite of bio-molecular computation tools. Additionally, Cyrus Biotechnology offers specialized services like Cyrus CryoEM, which focuses on structure refinement and model building for complex biomolecular structures. Its innovative software solutions cater to pharmaceutical companies, biotech firms, and startups engaged in discovering therapeutics and developing novel consumer products.
EarthOptics
Series A in 2021
EarthOptics is a company focused on sustainable agricultural management through the development of a global soil cloud platform. Utilizing advanced sensors and machine learning, EarthOptics creates highly accurate soil maps by analyzing far fewer soil samples. The platform provides detailed insights into various soil attributes, including compaction, fertility, and carbon levels. This technology empowers farmers, ranchers, and land managers to make informed decisions that enhance profitability and sustainability in soil management. Additionally, EarthOptics offers near-real-time actionable data that aids in monitoring soil health, benefiting both agricultural practices and carbon credit verification efforts.
Flywheel.io
Series C in 2021
Flywheel is a data management and analysis platform built specifically for scientists and the researcher's workflow. They empower research momentum by focusing on data and medical image capture, content management, scientific computation, and collaboration. With reproducible research in mind, they combine open-source methods from top universities, a modern web user interface, and an extensible compute engine based on containerization technology. The result is a software platform to accelerate discovery and help researchers do science, not IT. Flywheel accelerates new scientific discoveries in life-science, biotech, and academic imaging research through cloud-scale collaboration. As a result, imaging researchers are able to avoid innovation bottlenecks, and accelerate discovery by doing more science, and less IT.
Sentera
Series C in 2021
Sentera, Inc. specializes in designing, manufacturing, and distributing integrated software and sensor products primarily for the agriculture sector, along with applications in mining, infrastructure, security, and public safety. Founded in 2014 and based in Minneapolis, the company offers advanced technologies including drone sensors and video services, as well as the OnTop mobile app and desktop client for inspections. Sentera employs machine learning and data science to provide decision support and insights, enabling growers, advisors, and enterprise customers to optimize cultivation outcomes. By leveraging high-resolution drone imagery, satellite data, and other sensor inputs, Sentera delivers reliable plant-level measurements and analytics that facilitate informed decision-making and improved performance in agricultural practices.
Kula Bio
Seed Round in 2021
Kula Bio, Inc. is focused on developing innovative biological solutions for modern agriculture. Founded in 2018 and based in Somerville, Massachusetts, the company specializes in the production of organic biofertilizers using nitrogen-fixing microbes charged with renewable energy. By enhancing natural microbial processes, Kula Bio aims to create affordable and sustainable fertilization methods that enable farmers to increase their yields while promoting environmental stewardship. The company's approach seeks to disrupt traditional synthetic fertilizers, bridging the gap between effective agricultural practices and the responsible management of natural resources.
Molecular Assemblies
Series A in 2021
Molecular Assemblies, Inc. is a San Diego-based company specializing in enzymatic DNA synthesis technology, which facilitates the development of DNA-based products across various industries. Founded in 2013, the company focuses on creating long, high-quality, sequence-specific DNA in a reliable, affordable, and sustainable manner, inspired by natural processes. Its technology has applications in industrial synthetic biology, personalized therapeutics, precision diagnostics, information storage, nanotechnology, and DNA electronics. The firm boasts a skilled executive and scientific team, supported by a robust intellectual property portfolio. Molecular Assemblies has garnered investments from a range of venture capital sources, indicating strong interest in its innovative approach to DNA synthesis.
Pattern Ag
Venture Round in 2021
Pattern Ag specializes in soil microbiome analysis, offering farmers insights to optimize their agricultural inputs. The company's precision agriculture platform utilizes high-resolution mapping of soil DNA to provide actionable intelligence tailored to the specific pest and disease challenges faced by corn and soybean farmers. By delivering recommendations on crop protection, seed selection, and fertility needs, Pattern Ag helps farmers make informed decisions about what to purchase and when to apply these solutions. This focus on data-driven insights not only aims to enhance crop yields but also to improve overall farm productivity and sustainability.
Stony Creek Colors
Series B in 2021
Stony Creek Colors, Inc. is a manufacturer of bio-based colorants specifically designed for the textile industry. Founded in 2012 and based in Springfield, Tennessee, the company collaborates with small farmers in the Southeast U.S. to produce plant-based dyes, including indigo. Stony Creek Colors aims to provide clean and safe natural dyes that replace hazardous chemicals traditionally used in textile manufacturing. By focusing on sustainable practices, the company enables the textile and fashion industries to offer environmentally conscious premium products to consumers.
Benson Hill
Series D in 2020
Benson Hill is an agricultural technology company that specializes in crop improvement and soy protein innovation. The company focuses on unlocking the natural genetic diversity of plants to develop healthier, more sustainable food and ingredients. Its proprietary CropOS platform leverages machine learning and big data alongside traditional breeding techniques to streamline and expedite the product development process. Benson Hill operates a Crop Accelerator designed for rapid prototyping and is actively developing a seed portfolio that includes protein ingredients, aquaculture, specialty animal feed, and vegetable oils. The company generates revenue from both proprietary and non-proprietary product categories, with proprietary revenue stemming from the sale of its unique bean varieties.
TradeLanes
Seed Round in 2020
TradeLanes is a technology company based in Oakland, California, founded in 2015. It offers a software-as-a-service (SaaS) platform that automates and digitizes supply chain processes for traders, shippers, and merchants. The platform connects various participants in international trade, allowing them to collaborate seamlessly through a single document chain throughout the lifecycle of a shipment. By integrating demand planning, supplier performance, inventory management, and logistics into one application, TradeLanes aims to streamline global trade operations and reduce costs associated with supply chain management. The company's mission is to facilitate frictionless global trade for all involved parties.
Geltor
Series B in 2020
Geltor, Inc. is a biodesign company based in San Leandro, California, that specializes in producing bioactive, animal-free collagens and proteins for various applications in beauty, nutrition, and wellness. Established in 2015, Geltor offers innovative products such as Collume, which promotes skincare cellular regeneration and dermal synthesis, and HumaColl21, which enhances skin health by boosting collagen and elastin levels. Additionally, the company provides vegan collagen peptides and other novel proteins designed for functional food and nutraceutical formulations. Geltor's products are sustainably cultivated and clinically validated, allowing businesses to create effective, plant-based solutions that contribute to a more sustainable future.
One.bio
Venture Round in 2020
One.bio is a biotechnology spinout from UC Davis that specializes in developing naturally-derived oligosaccharides for applications in food, agriculture, and biopharmaceuticals. Utilizing proprietary technology, the company creates innovative ingredients aimed at modulating the microbiome and enhancing immune function. This focus allows One.bio to provide clients with access to novel prebiotics and therapies that support both human and animal health. By unlocking the benefits of nutrition, One.bio aims to contribute to improved longevity and overall well-being.
MOBILion Systems
Series A in 2019
MOBILion Systems, Inc. is a biotechnology company focused on advancing the detection and analysis of clinically relevant molecules that conventional instruments struggle to identify. The company has developed structures for lossless ion manipulation (SLIM), which facilitate ion mobility separations and enable researchers to detect minute traces of disease-specific biomolecules. Founded in 2015 and based in Chadds Ford, Pennsylvania, MOBILion's technology enhances the sensitivity, resolution, and throughput of analytical instruments. This innovation supports the identification of biologic therapeutics, accelerates biomarker discovery, and improves the accuracy of diagnostic tests. By processing large-scale samples efficiently, MOBILion aims to contribute to better disease prediction, diagnosis, and treatment, ultimately empowering clinicians and researchers to address diseases at their core rather than merely treating symptoms.
Molecular Assemblies
Series A in 2019
Molecular Assemblies, Inc. is a San Diego-based company specializing in enzymatic DNA synthesis technology, which facilitates the development of DNA-based products across various industries. Founded in 2013, the company focuses on creating long, high-quality, sequence-specific DNA in a reliable, affordable, and sustainable manner, inspired by natural processes. Its technology has applications in industrial synthetic biology, personalized therapeutics, precision diagnostics, information storage, nanotechnology, and DNA electronics. The firm boasts a skilled executive and scientific team, supported by a robust intellectual property portfolio. Molecular Assemblies has garnered investments from a range of venture capital sources, indicating strong interest in its innovative approach to DNA synthesis.
Benson Hill
Series C in 2019
Benson Hill is an agricultural technology company that specializes in crop improvement and soy protein innovation. The company focuses on unlocking the natural genetic diversity of plants to develop healthier, more sustainable food and ingredients. Its proprietary CropOS platform leverages machine learning and big data alongside traditional breeding techniques to streamline and expedite the product development process. Benson Hill operates a Crop Accelerator designed for rapid prototyping and is actively developing a seed portfolio that includes protein ingredients, aquaculture, specialty animal feed, and vegetable oils. The company generates revenue from both proprietary and non-proprietary product categories, with proprietary revenue stemming from the sale of its unique bean varieties.
Journeys Metabolic
Seed Round in 2019
Journeys Metabolic is a digital solution provider focused on metabolic care, specifically addressing obesity and Type 2 diabetes. The company offers a six-month, in-home program that integrates advanced technology, including AI-driven precision pathways and computer vision for food education, to facilitate sustained behavior modification. This HITRUST-compliant platform is designed to help health systems transition to value-based care without adding to the burden on care teams. By targeting insulin resistance and related chronic conditions, Journeys Metabolic supports shared savings optimization in metabolic diseases and nutrition-related disorders through tailored nutritional interventions. The program aims to improve patient outcomes by extending primary care into the home and fostering a fee-for-outcomes model in healthcare.
Artemis
Series A in 2019
Artemis develops a cultivation management platform designed for enterprise greenhouses, indoor farms, and high tunnel farms. This software enables growers to efficiently manage people, plants, processes, and compliance by providing a comprehensive view of facility productivity. Users can track operations and production data remotely through desktops, tablets, or smartphones. The platform allows owners and managers to oversee workflows, register crop batches, address food safety issues, manage personnel, and gain insights to enhance crop productivity. Founded in 2015 and originally named Agrilyst, the company rebranded to Artemis in May 2019 and is headquartered in Brooklyn, New York.
Benson Hill
Series C in 2018
Benson Hill is an agricultural technology company that specializes in crop improvement and soy protein innovation. The company focuses on unlocking the natural genetic diversity of plants to develop healthier, more sustainable food and ingredients. Its proprietary CropOS platform leverages machine learning and big data alongside traditional breeding techniques to streamline and expedite the product development process. Benson Hill operates a Crop Accelerator designed for rapid prototyping and is actively developing a seed portfolio that includes protein ingredients, aquaculture, specialty animal feed, and vegetable oils. The company generates revenue from both proprietary and non-proprietary product categories, with proprietary revenue stemming from the sale of its unique bean varieties.
HerdDogg
Seed Round in 2018
HerdDogg, Inc. specializes in real-time livestock monitoring systems that assist producers in tracking their herds. The company offers a mobile app and software platform that provides insights into breeding, animal health, and traceability for individual animals. This system utilizes DoggTag ear tags, which are attached to the animals, and DoggBone, a passive device that collects data on the activity, health, and location of the herd. HerdDogg's technology is applicable across various livestock industries, including beef, bison, dairy, and sheep. Founded in 2015 and headquartered in Ashland, Oregon, the company aims to enhance herd health management through data science and innovative monitoring solutions.
Shield Bio
Series A in 2018
Shield Bio focuses on combating antibiotic resistance, which is projected to surpass cancer as a leading cause of death by 2050. With infections like gonorrhea becoming resistant to numerous antibiotics, resulting in over 820,000 new cases annually in the U.S., the urgency to address this crisis has escalated. Shield Bio has developed an innovative genomic testing platform that allows sexually transmitted infection (STI) clinics to identify antibiotic-resistant strains of pathogens. This technology enables healthcare providers to determine the most effective antibiotics for treatment, thereby improving patient outcomes and helping to prevent the further spread of antibiotic resistance. By enhancing the accuracy and speed of susceptibility testing, Shield Bio aims to tackle one of the most significant challenges in modern medicine.
Entac Medical
Series A in 2018
Entac Medical is focused on developing medical devices that enhance predictive and diagnostic medicine through a unique technology based on audio spectral analysis. The company's primary product, PrevisEA, is a noninvasive, disposable device that has been clinically validated to predict postoperative ileus (POI) in surgical patients. POI, a condition occurring in 25% of patients within 2-6 days post-surgery, can lead to significant complications and hospital readmissions. By accurately predicting the risk of ileus, PrevisEA aims to improve treatment protocols and patient outcomes while also reducing unnecessary treatment costs for hospitals. The company seeks to address unmet medical needs in postoperative care, ultimately facilitating a more efficient surgical process for patients and healthcare providers.
Artemis
Corporate Round in 2018
Artemis develops a cultivation management platform designed for enterprise greenhouses, indoor farms, and high tunnel farms. This software enables growers to efficiently manage people, plants, processes, and compliance by providing a comprehensive view of facility productivity. Users can track operations and production data remotely through desktops, tablets, or smartphones. The platform allows owners and managers to oversee workflows, register crop batches, address food safety issues, manage personnel, and gain insights to enhance crop productivity. Founded in 2015 and originally named Agrilyst, the company rebranded to Artemis in May 2019 and is headquartered in Brooklyn, New York.
Bonumose
Series A in 2017
Bonumose LLC, established in 2016 and based in Charlottesville, Virginia, specializes in producing innovative food ingredients aimed at providing healthier alternatives to traditional sugars. The company focuses on developing sugar substitutes, particularly tagatose and allulose, utilizing a proprietary enzymatic technology breakthrough created by Dr. Daniel Wichelecki. These alternatives address health issues such as diabetes, obesity, and tooth decay by being low-glycemic and non-cariogenic, thus supporting glycemic control and improved gut health. Bonumose aims to position itself among the most trusted manufacturers of food ingredients globally, driven by a commitment to ethical business practices and the wellness of consumers.
Cofactor Genomics
Series A in 2017
Cofactor Genomics is a biotechnology company that specializes in predictive immune modeling and RNA sequencing. By advancing precision medicine, Cofactor aims to address existing barriers in the healthcare sector, transitioning from single-analyte biomarkers to comprehensive multidimensional biomarkers through health expression models. The company operates one of the first CAP-certified clinical RNA sequencing laboratories, which enhances the efficiency and cost-effectiveness of clinical trials for their partners. Cofactor’s expertise encompasses molecular biology, informatics, and database management, allowing them to provide high-quality services tailored to the needs of the healthcare and pharmaceutical industries. Their focus on RNA biomarkers associated with responses to targeted therapeutics supports the commercialization of clinical diagnostic assays for oncologic, immunologic, and neurodegenerative diseases, ultimately contributing to medical research and improved patient outcomes.
Agrible
Series B in 2017
Agrible, Inc. is an agricultural technology company based in Champaign, Illinois, focused on developing software solutions to enhance farming operations globally. Founded in 2007 by Bill Northcott, Chris Harbourt, and Paul Miller, the company provides various tools to assist growers in making informed decisions. Its flagship product, Morning Farm Report, offers detailed forecasts and data on yield predictions, nutrient availability, and weather conditions, among other critical factors. Agrible also features Find My Seed, which aggregates third-party seed trial data, and Pocket Rain Gauge, delivering localized rainfall measurements. Other applications include Pocket Spray Smart, which provides field-specific spraying conditions, and Pocket Drone Control, which aids in crop damage assessments by offering aerial views of fields. Agrible serves a diverse clientele, including independent growers, major food brands, and agricultural consultants, enabling them to optimize production and sustainability through advanced predictive analytics and field-level insights.
PopBookings
Venture Round in 2017
PopBookings is a cloud-based staffing solution that specializes in automating the hiring process for temporary and promotional staffing companies. Founded in 2014 and headquartered in Lenexa, Kansas, the company offers a comprehensive platform that simplifies booking and communication between agencies and event workers. Its features include database management, a custom-branded talent portal, drag-and-drop scheduling, geo check-ins, and an event dashboard with status alerts. By connecting brands with everyday individuals for promotional events, PopBookings enhances the efficiency of the staffing process, making it straightforward and accessible for all parties involved.
Benson Hill
Series B in 2017
Benson Hill is an agricultural technology company that specializes in crop improvement and soy protein innovation. The company focuses on unlocking the natural genetic diversity of plants to develop healthier, more sustainable food and ingredients. Its proprietary CropOS platform leverages machine learning and big data alongside traditional breeding techniques to streamline and expedite the product development process. Benson Hill operates a Crop Accelerator designed for rapid prototyping and is actively developing a seed portfolio that includes protein ingredients, aquaculture, specialty animal feed, and vegetable oils. The company generates revenue from both proprietary and non-proprietary product categories, with proprietary revenue stemming from the sale of its unique bean varieties.
Holganix
Venture Round in 2017
Holganix, Inc. is a manufacturer of plant-based bio-stimulant soil supplements aimed at enhancing soil health and promoting sustainable plant growth. Founded in 2010 and headquartered in Glen Mills, Pennsylvania, the company offers a range of products including tree and shrub solutions, golf course treatments, agriculture products, and flower programs. A key offering is Holganix Bio 800+, which contains beneficial microorganisms, microbe food, and nutrient enhancers that optimize soil conditions. Holganix's products are designed to reduce fertilizer use by up to 90%, thereby lowering costs for landscape and lawn care companies while minimizing environmental impact. The company sells its products through distributors in the United States and also offers online sales.
Honcho
Seed Round in 2016
Honcho is the only AI-powered communications protection software that coaches and trains as employees type to help compliance and HR professionals build and maintain exceptional communications practices in their companies. Our communications-protection software helps reduce the risk of non-compliant communications. Detect when users are composing potentially problematic messages, have the ability to archive official communication channels, and support supervisory review of any issues that arise. Show employees, customers, and the world that you care about ensuring an ethical and compliant workplace. And, invest in your communications now to avoid costly litigation, regulatory fines, negative press, and a demoralized culture later.
Euclises Pharmaceuticals
Venture Round in 2016
Euclises Pharmaceuticals, Inc. is engaged in the research, development, and commercialization of innovative medicines targeting inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company focuses on creating novel pain and cancer medications that promise enhanced safety profiles compared to current therapies. The firm is built on pioneering inventions by Dr. John Talley, a renowned medicinal chemist known for developing Celebrex among other approved drugs. Euclises aims to introduce new compounds that provide improved efficacy and safety, positioning itself as a leader in the pharmaceutical industry. The company operates from the BioGenerator Accelerator Labs, where it continues to advance its research initiatives.
AmpliFund
Series A in 2016
AmpliFund provides a cloud-based grant management software solution that serves both grant makers and grant seekers, facilitating the entire grant life-cycle. The platform enables users to streamline processes, centralize data and documentation, and enhance both quantitative and qualitative reporting. By automating various activities throughout the grant management process, AmpliFund drives standardization, efficiency, transparency, and compliance, which are crucial for accountability in grant program outcomes. Founded by professionals with expertise in grant management, the company focuses on empowering state, local, and tribal governments to maximize their funding potential and create capacity within their teams. Through its innovative tools and resources, AmpliFund aims to simplify business processes and amplify grant resources to support impactful missions.
Bractlet
Venture Round in 2016
Bractlet, Inc. is an Austin, Texas-based company that specializes in developing an energy intelligence platform aimed at maximizing energy efficiency project value. Founded in 2011, Bractlet provides integrated hardware and software solutions designed to analyze business performance and reduce energy waste. Its hardware includes a commercial electrical panel that accommodates up to 42 branch circuits, while its measurement and verification software generates reports for stakeholders. The company also offers services related to building energy modeling and big data, positioning itself as a leader in optimizing building performance and enhancing capital investment in the real estate sector.
Kultevat
Venture Round in 2016
Kultevat, Inc. is a biotechnology company focused on the cultivation and processing of dandelion varieties to produce natural rubber. The company primarily works with TKS Dandelion, a domestic source of rubber in the United States, Canada, and Europe, and also extracts rubber from Russian Dandelion. Kultevat's offerings include latex and bulk rubber products used in a variety of applications such as gloves, medical devices, and automotive parts, as well as renewable food co-products and sugar feedstocks for biofuel production. Founded in 2013 and based in Portageville, Missouri, Kultevat aims to provide sustainable alternatives to synthetic rubber, contributing positively to agricultural markets and reducing environmental impact.
Epharmix
Seed Round in 2016
Epharmix, Inc. is a digital healthcare company that specializes in developing clinically validated, condition-specific communication tools for the healthcare industry. Founded in 2015 and based in Saint Louis, Missouri, Epharmix provides digital interventions designed to enhance patient-physician engagement, automate the collection of clinical data, and alert healthcare providers for effective chronic care management. Its products aim to improve care for underserved patients while also reducing the workload of care teams, ultimately enhancing patient engagement and health outcomes.
StreamLink Software
Venture Round in 2016
StreamLink Software-is a Software-as-a-Service company that develops grant management software for nonprofits and the public sector. Ther grants management solution, AmpliFund, is designed for managing every stage of the grant lifecycle and is at the forefront of automating grant compliance and data standardization in the public sector. It was founded in 2008 and is headquartered in Cleveland, Ohio.
Neuros Medical
Venture Round in 2016
Neuros Medical, Inc. is a neuromodulation company based in Willoughby Hills, Ohio, that specializes in developing proprietary neurostimulation therapies aimed at addressing unmet medical needs for patients globally. The company's flagship technology, known as Electrical Nerve Block, targets chronic pain conditions, including neuroma and residual limb pain, chronic post-surgical pain, and chronic migraine. Neuros Medical also offers the Neuros Altius System, which features an implantable generator with an integrated rechargeable battery, a cuff electrode, and associated external devices. Established in 2008, the company is dedicated to advancing innovative solutions for pain management.
Open Studio Network
Seed Round in 2015
Open Studio Network Access to premier musical artists, through a simple, interactive online lesson platform.
Mentor Spaces
Venture Round in 2015
Mentor Spaces is a community-focused mentorship platform aimed at helping companies attract, hire, and retain underrepresented talent. The platform serves as a networking space for underrepresented professionals, enabling them to connect with industry experts who share similar professional interests and goals. By fostering these relationships, Mentor Spaces allows companies to engage with diverse talent prior to formal recruitment events, enhancing their efforts to build a more inclusive workforce. Through its unique approach, the platform supports both individuals seeking mentorship and organizations looking to improve their diversity initiatives.
Antegrin Therapeutics
Seed Round in 2015
Antegrin Therapeutics, LLC, is a drug discovery and development company focused on the development of novel therapies for fibrotic diseases. Our lead program aims to develop a treatment for idiopathic pulmonary fibrosis, a progressive, life-threatening condition that currently has no FDA-approved medication.
Euclises Pharmaceuticals
Venture Round in 2015
Euclises Pharmaceuticals, Inc. is engaged in the research, development, and commercialization of innovative medicines targeting inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company focuses on creating novel pain and cancer medications that promise enhanced safety profiles compared to current therapies. The firm is built on pioneering inventions by Dr. John Talley, a renowned medicinal chemist known for developing Celebrex among other approved drugs. Euclises aims to introduce new compounds that provide improved efficacy and safety, positioning itself as a leader in the pharmaceutical industry. The company operates from the BioGenerator Accelerator Labs, where it continues to advance its research initiatives.
BenchmarkONE
Seed Round in 2015
BenchmarkONE develops sales and marketing automation software tailored for small and mid-sized businesses. The company offers an integrated platform that includes customer relationship management (CRM) tools and sales automation features, allowing users to monitor contacts' activities, track deals, manage communications, and segment their audience. Additionally, BenchmarkONE provides email marketing capabilities with a user-friendly drag-and-drop email builder and marketing automation tools designed to engage visitors, prioritize leads, and optimize campaign investments. Originally known as Hatchbuck, Inc., the company rebranded to BenchmarkONE in June 2020 and has been operational since 2010, with its headquarters in St. Louis, Missouri. As of September 2019, BenchmarkONE functions as a subsidiary of Benchmark Internet Group, LLC.
Bractlet
Seed Round in 2015
Bractlet, Inc. is an Austin, Texas-based company that specializes in developing an energy intelligence platform aimed at maximizing energy efficiency project value. Founded in 2011, Bractlet provides integrated hardware and software solutions designed to analyze business performance and reduce energy waste. Its hardware includes a commercial electrical panel that accommodates up to 42 branch circuits, while its measurement and verification software generates reports for stakeholders. The company also offers services related to building energy modeling and big data, positioning itself as a leader in optimizing building performance and enhancing capital investment in the real estate sector.
Ward Alternative Energy
Venture Round in 2015
Ward Alternative Energy was born from a passion to provide American, low cost, clean transportation fuels for vehicles. Discovering, producing and compressing natural gas in the field is a deep upstream expertise built over the past 50 years at Ward Petroleum. At Ward Alternative Energy, we add the down-stream natural gas, fueling and NGV expertise of our industry veterans. Our team is well prepared to be the natural gas fuels, station services and vehicle services provider and partner of choice for fleets. We started our business in Colorado in 2012 but are now expanding to Wyoming, New Mexico, northwest Texas and east through Kansas to St. Louis.
BenchmarkONE
Venture Round in 2015
BenchmarkONE develops sales and marketing automation software tailored for small and mid-sized businesses. The company offers an integrated platform that includes customer relationship management (CRM) tools and sales automation features, allowing users to monitor contacts' activities, track deals, manage communications, and segment their audience. Additionally, BenchmarkONE provides email marketing capabilities with a user-friendly drag-and-drop email builder and marketing automation tools designed to engage visitors, prioritize leads, and optimize campaign investments. Originally known as Hatchbuck, Inc., the company rebranded to BenchmarkONE in June 2020 and has been operational since 2010, with its headquarters in St. Louis, Missouri. As of September 2019, BenchmarkONE functions as a subsidiary of Benchmark Internet Group, LLC.
Immunophotonics
Series A in 2015
ImmunoPhotonics, Inc. is a biotechnology company focused on developing innovative immunotherapy treatments for cancer, specifically targeting metastatic solid tumors. Founded in 2008 and located in Columbia, Missouri, the company has created a proprietary drug product designed to function as a minimally invasive therapeutic cancer vaccine. This product is administered through intratumoral injection following tumor ablation, leveraging tumor-associated neoantigens to stimulate a systemic anti-tumor immune response. By transforming the process of tumor ablation into a therapeutic approach, ImmunoPhotonics aims to enhance treatment options for patients with late-stage metastatic cancers. The company has also established a strategic partnership with Veterinary Cancer Therapeutics, LLC to further its mission in cancer treatment.
Kultevat
Venture Round in 2015
Kultevat, Inc. is a biotechnology company focused on the cultivation and processing of dandelion varieties to produce natural rubber. The company primarily works with TKS Dandelion, a domestic source of rubber in the United States, Canada, and Europe, and also extracts rubber from Russian Dandelion. Kultevat's offerings include latex and bulk rubber products used in a variety of applications such as gloves, medical devices, and automotive parts, as well as renewable food co-products and sugar feedstocks for biofuel production. Founded in 2013 and based in Portageville, Missouri, Kultevat aims to provide sustainable alternatives to synthetic rubber, contributing positively to agricultural markets and reducing environmental impact.
Gremlin Social
Seed Round in 2014
Gremlin Social is a developer of an integrated social media management platform tailored specifically for financial institutions. The company provides a comprehensive suite of organizational tools that streamline social media marketing campaigns, content management, and analytics, all within a centralized dashboard. This enables businesses to efficiently engage with customers across multiple platforms, including Twitter, Facebook, and LinkedIn, while saving time and resources. Gremlin Social offers features such as team management, scheduled and recurring posts, keyword filtration, branded reports, and advanced analytics. The platform is recognized by the American Bankers Association and the New York Bankers Association as the preferred social media management and compliance toolkit for member institutions. Additionally, Gremlin Social provides enterprise and white label options, ensuring that banks and financial services can effectively manage their social media presence and enhance customer engagement.
Immunophotonics
Series A in 2014
ImmunoPhotonics, Inc. is a biotechnology company focused on developing innovative immunotherapy treatments for cancer, specifically targeting metastatic solid tumors. Founded in 2008 and located in Columbia, Missouri, the company has created a proprietary drug product designed to function as a minimally invasive therapeutic cancer vaccine. This product is administered through intratumoral injection following tumor ablation, leveraging tumor-associated neoantigens to stimulate a systemic anti-tumor immune response. By transforming the process of tumor ablation into a therapeutic approach, ImmunoPhotonics aims to enhance treatment options for patients with late-stage metastatic cancers. The company has also established a strategic partnership with Veterinary Cancer Therapeutics, LLC to further its mission in cancer treatment.
Time to Cater
Seed Round in 2014
Time to Cater is a web-based platform designed to assist companies and individuals in organizing catered events without incurring additional costs. Users simply input their event details, food preferences, and budget into the platform, which then manages the entire catering process. This includes coordinating with caterers, selecting menus, and ensuring quality control. By streamlining communication and order placement, Time to Cater eliminates the time-consuming task of contacting multiple caterers for availability and pricing. The service is funded through commissions from caterers within its Preferred Caterer Network, allowing clients to enjoy a seamless catering experience from start to finish at no extra charge.
CrazyForEducation
Seed Round in 2014
CrazyForEducation LLC is an educational technology company based in St. Louis, Missouri, founded in 2012 by Dr. Renato Cataldo. The company specializes in developing online teaching software and educational tools tailored for K-12 schools, teachers, students, and professionals. Its platform supports flip teaching by providing professional development resources, including recorded webinars and feedback videos for educators and students. Key features of the platform include tools for lesson assignments, digital note-taking, course management, and student organization. Additionally, CrazyForEducation offers uTutor.me, which allows users to access video lessons from K-12 and college educators, and ClinPharmEd, an online educational system for clinical pharmacists and pharmacy students. The company's mission is to enhance the educational experience through adaptive teaching models and comprehensive support for schools and districts.
Benson Hill
Seed Round in 2014
Benson Hill is an agricultural technology company that specializes in crop improvement and soy protein innovation. The company focuses on unlocking the natural genetic diversity of plants to develop healthier, more sustainable food and ingredients. Its proprietary CropOS platform leverages machine learning and big data alongside traditional breeding techniques to streamline and expedite the product development process. Benson Hill operates a Crop Accelerator designed for rapid prototyping and is actively developing a seed portfolio that includes protein ingredients, aquaculture, specialty animal feed, and vegetable oils. The company generates revenue from both proprietary and non-proprietary product categories, with proprietary revenue stemming from the sale of its unique bean varieties.
adFreeq
Seed Round in 2014
adFreeq, LLC is a company that offers a personalized classified advertisement platform, allowing buyers and sellers to connect in real-time. The primary product, adFreeq adPortal, is a versatile JavaScript widget or WordPress plug-in that publishers, including online newspapers and media companies, can easily embed on their websites. This self-managed, cloud-based service requires no hardware or software installation for media publishers, enabling them to provide a seamless classified ad experience. Users can browse tailored advertisements sourced from social media, regional and national classified publishers, as well as the adFreeq network. Founded in 2011 and headquartered in Columbia, Missouri, adFreeq also has additional locations in the United States and China.
adFreeq
Angel Round in 2014
adFreeq, LLC is a company that offers a personalized classified advertisement platform, allowing buyers and sellers to connect in real-time. The primary product, adFreeq adPortal, is a versatile JavaScript widget or WordPress plug-in that publishers, including online newspapers and media companies, can easily embed on their websites. This self-managed, cloud-based service requires no hardware or software installation for media publishers, enabling them to provide a seamless classified ad experience. Users can browse tailored advertisements sourced from social media, regional and national classified publishers, as well as the adFreeq network. Founded in 2011 and headquartered in Columbia, Missouri, adFreeq also has additional locations in the United States and China.
Tansna Therapeutics
Seed Round in 2014
Tansna Therapeutics, Inc. is a drug discovery and development company based in St. Louis, Missouri, founded in 2010. The company specializes in creating and commercializing oral drugs aimed at treating epilepsy and other central nervous system disorders. Its primary focus is on developing novel oral anticonvulsant agents designed to effectively reduce seizure frequency in patients with epilepsy. By providing safe and innovative treatment options, Tansna Therapeutics aims to enhance the quality of care for individuals suffering from these debilitating conditions.
Time to Cater
Angel Round in 2014
Time to Cater is a web-based platform designed to assist companies and individuals in organizing catered events without incurring additional costs. Users simply input their event details, food preferences, and budget into the platform, which then manages the entire catering process. This includes coordinating with caterers, selecting menus, and ensuring quality control. By streamlining communication and order placement, Time to Cater eliminates the time-consuming task of contacting multiple caterers for availability and pricing. The service is funded through commissions from caterers within its Preferred Caterer Network, allowing clients to enjoy a seamless catering experience from start to finish at no extra charge.
Tansna Therapeutics
Angel Round in 2013
Tansna Therapeutics, Inc. is a drug discovery and development company based in St. Louis, Missouri, founded in 2010. The company specializes in creating and commercializing oral drugs aimed at treating epilepsy and other central nervous system disorders. Its primary focus is on developing novel oral anticonvulsant agents designed to effectively reduce seizure frequency in patients with epilepsy. By providing safe and innovative treatment options, Tansna Therapeutics aims to enhance the quality of care for individuals suffering from these debilitating conditions.
Time to Cater
Angel Round in 2013
Time to Cater is a web-based platform designed to assist companies and individuals in organizing catered events without incurring additional costs. Users simply input their event details, food preferences, and budget into the platform, which then manages the entire catering process. This includes coordinating with caterers, selecting menus, and ensuring quality control. By streamlining communication and order placement, Time to Cater eliminates the time-consuming task of contacting multiple caterers for availability and pricing. The service is funded through commissions from caterers within its Preferred Caterer Network, allowing clients to enjoy a seamless catering experience from start to finish at no extra charge.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.